Atherosclerosis: cell biology and lipoproteins--new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells.
E. Karshovska,C. Weber
DOI: https://doi.org/10.1097/MOL.0b013e3283555a9c
IF: 4.616
2012-08-01
Current Opinion in Lipidology
Abstract:DOI:10.1097/MOL.0b013e3283555a9c Atherosclerosis is characterized by chronic inflammation of the arterial wall, mediated by adhesion and secretion of activated platelets, neutrophils and monocytes, as well as T cells and dendritic cells infiltrating the vascular lesion [1 && ,2]. Investigation of new targets will advance our understanding about cellular dynamics in the pathophysiology of atherosclerosis and will enable development of diagnostic and early therapy approaches for prevention and treatment of cardiovascular disease. Oxidatively modified LDL (oxLDL) confer lysophosphatidylcholine, which is the main substrate for generation of lysophosphatidic acid (LPA) by autotaxin during atherogenesis [3 && ,4]. Recently, Zhou et al. [3 && ] investigated the role of LPA in lipoprotein-induced monocyte recruitment and atherosclerosis. Interestingly, unsaturated LPA promoted plaque progression, macrophage accumulation and leukocyte recruitment to the vessel wall during early atherosclerosis [3 && ,5], mediating oxLDL-induced monocyte adhesion through the CXCL1/CXCR2 chemokine axis and endothelial LPA receptors. Of interest, LPA2 expression is downregulated, whereas LPA1 and LPA3 are expressed in lesional endothelial cells. In line with these observations, blocking the LPA receptors LPA1 and LPA3 reduced hyperlipidemia-induced leukocyte arrest and macrophage accumulation through CXCL1, which sequentially reduced atherosclerosis. Thus, the identification of endothelial LPA receptors and their functions may offer new perspectives for therapeutic interventions. Furthermore, other known sources of LPA precursors are, for instance, activated platelets [4], whose role clearly extends beyond hemostasis and thrombosis [1 && ,6]. Notably, Postea et al. [7] recently discovered the involvement of CX3CL1 chemokine and its receptor CX3CR1 in platelet–monocyte complex (PMC) formation and monocyte recruitment during atherosclerosis. Moreover, human and mouse platelets overexpressed CX3CR1, which was implicated with an
Biology,Medicine